Cholecystokinin-8 enhances nerve growth factor synthesis and promotes recovery of capsaicin-induced sensory deficit

British Journal of Pharmacology

Volumn 129, Issue 4, 2000, Pages 744-750

  Manni, Luigi ^a,b   Lundeberg, Thomas ^b   Tirassa, Paola ^a,b   Aloe, Luigi ^a  

^a CNR   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Calcitonin gene related peptide (CGRP); Capsaicin; Cholecystokinin (CCK 8); Mice; Nerve growth factor (NGF); Peripheral neuropathies; Sensory response; Substance P (SP)

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; CHOLECYSTOKININ OCTAPEPTIDE; MESSENGER RNA; NERVE GROWTH FACTOR; SUBSTANCE P;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSORY DYSFUNCTION;

EID: 0034059336     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703088     Document Type: Article

References (39)

1. Ahmed, M., Bjurholm, A., Srinivasan, G.R., Theodorsson, E. & Kreicbergs, A. (1994). Extraction of neuropeptides from joint tissue for quantitation by radioimmunoassay. A study in the rat. Peptides, 15, 317-322.
2. Aloe, L., Moroni, R., Angelucci, F. & Fiore, M. (1997). Role of TNF-α but not NGF in murine hyperalgesia induced by parasitic infection. Psychopharmacology, 134, 287-292.
3. Aloe, L., Probert, L., Kollias, G., Micera, A. & Tirassa, P. (1995). Effect of NGF antibodies on mast cell distribution, histamine and substance P levels in the knee joint of TNF-arthritic transgenic mice. Rheumatol. Int., 14, 249-252.
4. Amann, R., Sirinathsinghji, D.J.S., Donnerer, J., Liebman, I. & Schuligoi, R. (1996). Stimulation by nerve growth factor of neuropeptide synthesis in the adult rat in vivo: Bilateral response to unilateral intraplantar injections. Neurosci. Lett., 203, 171-174.
5. Angelucci, F., Fiore, M., Cozzari, C. & Aloe, L. (1999). Effect of prenatal ethanol intake on nerve growth factor level and on the development of entorhinal cortex in postnatal mice. Neurotoxicol. Teratol., 21, 415-425.
6. Apfel, S.C., Arezzo, J.C., Brownlee, M., Federoff, H. & Kessler, J.A. (1994). Nerve growth factor protects against experimental diabetic sensory neuropathy. Brain Res., 634, 7-12.
7. Apfel, S.C., Kessler, J.A., Adornato, B.T., Litchy, V.J., Sanders, C. & Rask, C.A. (1998). Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. Neurology, 51, 695-702.
8. Barohn, R.J. (1998). Approach to peripheral neuropathy and neuronopathy. Sem. Neurol., 18, 7-18.
9. Bittner, M.A. & Lahann, T.R. (1984). Biphasic time-course of capsaicin-induced substance P depletion: failure to correlate with thermal analgesia in the rat. Brain Res., 322, 305-309.
10. Bracci-Laudiero, L., Aloe, L., Levi-Montalcini, R., Buttinelli, C., Schilter, D. Gillessen, S. & Otten, U. (1992). Multiple sclerosis patients express increased levels of β-nerve growth factor in cerebrospinal fluid. Neurosci. Lett., 147, 9-12.
11. Brodin, E., Lindefors, N., Theodorsson-Norheim, E. & Rosell, S. (1986). Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin A. Regul Pept., 13, 253-272.
12. Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
13. Crawley, J.N. & Beinfeld, M.C. (1983). Rapid development of tolerance to the behavioural actions of cholecystokinin. Nature, 302, 703-706.
14. Donnerer, J. (1996). Improved neurochemical recovery of 6-hydroxydopamine-lesioned postganglionic neurons by nerve growth factor in the adult rat. Neurosci. Lett., 221, 33-36.
15. Donnerer, J., Amann, R., Schuligoi, R. & Skofitsch, G. (1996). Complete recovery by nerve growth factor of neuropeptide content and function in capsaicin-impaired sensory neurons. Brain Res., 741, 103-108.
16. Gamse, R., Petsche, U., Lembeck, F. & Jancso, G. (1982). Capsaicin applied to peripheral nerve inhibits axoplasmic transport of Substance P and somatostatin. Brain Res., 239, 447-462.
17. Gibbins, I.L., Furness, J.B. & Costa, M. (1987). Pathway-specific patterns of the co-existence of substance P, calcitonin gene-related peptide, cholecystokinin and dynorphin in neurons of the dorsal root ganglia of the guinea pig. Cell Tissue Res., 248, 417-437.
18. Hellweg, R. & Hartung, H.D. (1990). Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J. Neurosci. Res., 26, 258-267.
19. Heumann, R., Korsching, S., Bandtlow, C. & Thoenen, H. (1987). Changes of nerve growth factor synthesis in non-neuronal cells in response to sciatic nerve transection. J. Cell. Biol., 104, 1623-1631.
20. Holzer, P. (1991). Capsaicin: cellular targets, mechanism of action, and selectivity for thin sensory neurons. Pharmacol. Rev., 43, 143-201.
21. Levi-Montalcini, R. (1987). The nerve growth factor 35 years later. Science, 237, 1154-1162.
22. Linden, A., Uvnas-Moberg, K., Forsberg, G., Bednar, I. & Sodersten, P. (1989). Plasma concentrations of cholecystokinin octapeptide and food intake in male rats treated with cholecystokinin octapeptide. J. Endocrinol., 121, 59-65.
23. Maggi, C.A., Santicioli, P., Geppetti, P., Furio, M., Frilli, S., Conte, B., Fanciullacci, M., Giuliani, S. & Meli, A. (1987). The contribution of capsaicin-sensitive innervation to activation of the spinal vescico-vescical reflex in rats: relationship between substance P levels in the urinary bladder and the sensory-efferent function of capsaicin-sensitive sensory neurons. Brain Res., 415, 1-13.
24. McMahon, S.B., Bennett, D.L., Priestley, J.V. & Shelton, D.L. (1995). The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nat. Med., 1, 774-780.
25. Miller, M.S., Buck, S.H., Sipes, I.G., Yamamura, H.I. & Burks, T.F. (1982). Regulation of substance P by nerve growth factor: disruption by capsaicin. Brain Res., 250, 193-196.
26. Podluso, J.F., Curran, G.L. & Gill, J.S. (1998). Putrescine-modified nerve growth factor: bioactivity, plasma pharmacokinetics, blood-brain/nerve barrier permeability, and nervous system biodistribution. J. Neurochem., 71, 1651-1660.
27. Rehfeld, J.F. (1980). Cholecystokinin. Trends Neurosci. 3, 65-67.
28. Ren, K., Thomas, D.A. & Dubner, R. (1995). Nerve growth factor alleviates a painful peripheral neuropathy in rats. Brain Res., 699, 286-292.
29. Sabath, D.E., Broome, H.E. & Prystowsky, M.B. (1990). Glyceraldeyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene, 91, 185-191.
30. Schicho, R., Skofitsch, G. & Donnerer, J. (1999). Regenerative effect of human recombinant NGF on capsaicin-lesioned sensory neurons in the adult rat. Brain Res., 815, 60-69.
31. Scott, J., Selby, M., Urdea, M., Quiroga, M., Bell, G.I. & Rutter, W.J. (1983). Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor. Nature, 302, 538-540.
32. Skofitsch, G. & Jacobowitz, D.M. (1985). Calcitonin gene-related peptide coexists with substance P in capsaicin sensitive neurons and sensory ganglia of the rat. Peptides, 6, 747-754
33. NGFR, Trk, TrkB and TrkC) in human peripheral neuropathies. Neurochem. Res., 23, 821-829.
34. Tirassa, P., Aloe, L., Stenfors, C., Turrini, P. & Lundeberg, T. (1999). Cholecystokinin-8 protects central cholinergic neurons against fimbria-fornix lesion through the up-regulation of nerve growth factor synthesis. Proc. Natl. Acad. Sci. U.S.A., 96, 6473-6477.
35. Tirassa, P., Stenfors, C., Lundeberg, T. & Aloe, L. (1998). Cholecystokinin-8 regulates NGF concentrations in adult mouse brain through a mechanism involving CCKA and CCKB receptors. Br. J. Pharmacol., 123, 1230-1236.
36. Tomlinson, D.R., Fernyhough, P. & Diemel, L.T. (1997). Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes, 46, S43-S49.
37. Verge, V.M.K., Richardson, P.M., Wiesenfeld-Hallin, Z. & Hökfelt, T. (1995). Differential influence of nerve growth factor on neuropeptide expression in vivo: a novel role in peptide suppression in adult sensory neurons. J. Neurosci., 15, 2081-2096.
38. Weskamp, J. & Otten, U. (1987). An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and peripheral tissues. J. Neurochem., 48, 1779-1786.
39. Younger, D.S., Rosoklija, G. & Hays, A.P. (1998). Diabetic peripheral neuropathy. Semin. Neurol., 18, 95-104.